1 g Omega-3 Per Day: Is It Enough?
If you have picked up a fish oil capsule, chances are the label says "1000 mg fish oil." But 1000 mg of fish oil is not the same as 1000 mg of omega-3. This distinction matters more than most people realize, and it is the main reason many supplement users are unknowingly under-dosing.
This guide breaks down what 1 g of omega-3 actually provides, who it works for, and when you should aim higher.
TL;DR
- 1 g of total omega-3 (not fish oil) per day is a solid baseline for general health
- Most 1000 mg fish oil capsules contain only 300–500 mg of actual omega-3 (EPA + DHA)
- The European Food Safety Authority considers up to 5 g/day of EPA+DHA safe (EFSA, 2012)
- For cardiovascular benefits, aim for at least 250 mg EPA + 250 mg DHA daily (EFSA, 2010)
- Athletes and people with inflammatory conditions may benefit from 2–3 g of EPA+DHA
Fish Oil vs. Omega-3: The Label Trap
A standard fish oil softgel advertised as "1000 mg" typically contains roughly 180 mg EPA and 120 mg DHA — just 300 mg of actual omega-3 fatty acids. The remaining 700 mg is other fats. You would need three of these capsules to reach the 1 g omega-3 mark (Harris et al., 2009).
Concentrated formulas are different. A high-quality concentrated omega-3 capsule may deliver 600–900 mg of EPA+DHA per gram, meaning a single capsule can genuinely provide close to 1 g of active omega-3.
Always read the supplement facts panel for the EPA + DHA line, not just the front label.
What Does 1 g of Omega-3 Actually Do?
Heart Health
The most robust evidence for omega-3 supplementation is cardiovascular. The VITAL trial (Manson et al., 2019), involving over 25,000 participants, found that 1 g/day of omega-3 (840 mg EPA+DHA) reduced major cardiovascular events by 28% in participants who ate less than 1.5 servings of fish per week.
EFSA has approved health claims for EPA and DHA contributing to the normal function of the heart at intakes of 250 mg/day (EFSA, 2010).
Brain Function
DHA makes up roughly 40% of the polyunsaturated fatty acids in the brain (McNamara & Carlson, 2006). At 1 g total omega-3, you are likely getting 300–500 mg DHA depending on the product, which meets or exceeds the EFSA-endorsed 250 mg threshold for supporting normal brain function.
Inflammation and Recovery
Omega-3 fatty acids are precursors to resolvins and protectins — molecules that actively resolve inflammation rather than just blocking it (Serhan et al., 2008). For general inflammation management, 1 g of EPA+DHA is a reasonable starting point, though athletic populations often benefit from higher doses (2–3 g) to manage exercise-induced inflammation (Jouris et al., 2011).
Who Does 1 g/Day Work For?
| Profile | 1 g EPA+DHA sufficient? | Notes |
|---|---|---|
| General adult health | Yes | Covers EFSA heart & brain claims |
| Light exercise (2–3x/week) | Yes | Adequate for baseline support |
| Endurance/strength athletes | Borderline | 2–3 g may better support recovery (Jouris et al., 2011) |
| Pregnancy/nursing | Borderline | 200 mg extra DHA recommended (Koletzko et al., 2007) |
| High triglycerides | No | 2–4 g EPA+DHA used in clinical settings (Skulas-Ray et al., 2019) |
| Low fish intake (<1 serving/week) | Yes, as minimum | Strong benefit vs. no supplementation |
Common Mistakes
1. Confusing fish oil dose with omega-3 dose. Three 1000 mg fish oil capsules may give you only 900 mg omega-3. Always check EPA + DHA content.
2. Ignoring the EPA:DHA ratio. For heart health, EPA-dominant formulas may be more effective. For cognitive support, DHA-dominant formulas are preferred (Mozaffarian & Wu, 2011).
3. Storing fish oil improperly. Oxidized omega-3 may do more harm than good. Keep capsules in a cool, dark place and discard if they smell strongly of fish (Albert et al., 2015).
4. Taking omega-3 on an empty stomach. Fat-soluble supplements absorb significantly better with a meal containing fat (Lawson & Hughes, 1988).
How to Choose a Product
Look for these markers on the label:
- EPA + DHA per serving clearly listed (not just "fish oil")
- Concentration of at least 50% (500 mg EPA+DHA per 1000 mg capsule)
- Third-party testing (IFOS, GOED, or similar)
- Triglyceride or re-esterified triglyceride form for better absorption vs. ethyl ester (Dyerberg et al., 2010)
At MaxFit.ee you can find concentrated omega-3 supplements that clearly list EPA and DHA content per capsule, making it easy to hit your target dose.
Estonia-Specific Considerations
Fish consumption in the Baltic region tends to be moderate, but many Estonians do not eat fatty fish (salmon, mackerel, herring) twice a week as recommended. If your weekly diet includes mostly lean fish like pike-perch or cod, supplementation becomes more relevant.
Prices for quality omega-3 in Estonia typically range from €10–25 for a month's supply, depending on concentration.
FAQ
Is 1 g of fish oil the same as 1 g of omega-3?
No. Standard fish oil is roughly 30% omega-3. You need about 3 standard capsules to get 1 g of actual EPA+DHA. Concentrated formulas can deliver 1 g in a single capsule.
Can you take too much omega-3?
EFSA considers up to 5 g/day of supplemental EPA+DHA safe for adults (EFSA, 2012). Higher doses can thin the blood slightly, so consult a doctor if you are on anticoagulants.
Should I take omega-3 in the morning or evening?
Timing does not matter much. What matters is taking it with a meal containing some fat to improve absorption (Lawson & Hughes, 1988).
Is plant-based omega-3 (ALA) equivalent?
ALA from flaxseed or walnuts converts to EPA and DHA at very low rates — roughly 5–10% for EPA and less than 1% for DHA (Burdge & Calder, 2005). If you avoid fish, consider algae-based EPA+DHA supplements instead.
References
- Albert, B.B. et al. (2015). Fish oil supplements in New Zealand are highly oxidised and do not meet label content of n-3 PUFA. Scientific Reports, 5, 7928.
- Burdge, G.C. & Calder, P.C. (2005). Conversion of alpha-linolenic acid to longer-chain polyunsaturated fatty acids in human adults. Reproduction Nutrition Development, 45(5), 581–597.
- Dyerberg, J. et al. (2010). Bioavailability of marine n-3 fatty acid formulations. Prostaglandins, Leukotrienes and Essential Fatty Acids, 83(3), 137–141.
- EFSA Panel on Dietetic Products (2010). Scientific Opinion on the substantiation of health claims related to EPA and DHA. EFSA Journal, 8(10), 1796.
- EFSA Panel on Dietetic Products (2012). Scientific Opinion on the tolerable upper intake level of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), and docosapentaenoic acid (DPA). EFSA Journal, 10(7), 2815.
- Harris, W.S. et al. (2009). Towards establishing dietary reference intakes for eicosapentaenoic and docosahexaenoic acids. Journal of Nutrition, 139(4), 804S–819S.
- Jouris, K.B. et al. (2011). The effect of omega-3 fatty acid supplementation on the inflammatory response to eccentric strength exercise. Journal of Sports Science and Medicine, 10(3), 432–438.
- Koletzko, B. et al. (2007). Dietary fat intakes for pregnant and lactating women. British Journal of Nutrition, 98(5), 873–877.
- Lawson, L.D. & Hughes, B.G. (1988). Absorption of eicosapentaenoic acid and docosahexaenoic acid from fish oil triacylglycerols or fish oil ethyl esters co-ingested with a high-fat meal. Biochemical and Biophysical Research Communications, 156(2), 960–963.
- Manson, J.E. et al. (2019). Marine n-3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer. New England Journal of Medicine, 380(1), 23–32.
- McNamara, R.K. & Carlson, S.E. (2006). Role of omega-3 fatty acids in brain development and function. Prostaglandins, Leukotrienes and Essential Fatty Acids, 75(4-5), 329–349.
- Mozaffarian, D. & Wu, J.H.Y. (2011). Omega-3 Fatty Acids and Cardiovascular Disease. Journal of the American College of Cardiology, 58(20), 2047–2067.
- Serhan, C.N. et al. (2008). Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nature Reviews Immunology, 8(5), 349–361.
- Skulas-Ray, A.C. et al. (2019). Omega-3 Fatty Acids for the Management of Hypertriglyceridemia. Circulation, 140(12), e673–e691.
See also:



